Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study. The research, ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Stock image of an older couple running (main) and amyloid plaques in the brain (inset). Alzheimer's disease could be slowed by aerobic exercise, researchers say. Stock image of an older couple ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...

Researchers from the University of Turku and Åbo Akademi University in Finland and the University of Wisconsin in the United States demonstrated that individuals who had childhood epilepsy have an ...

This study offers hope for a new approach to treating Alzheimer's disease. The US Food and ... s has been concentrated on targeting beta-amyloid plaques that build up in the brain.

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.